DUBLIN--(BUSINESS WIRE)--The "Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The breast lesion localization methods market is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period.
The breast lesion localization methods market is driven primarily by the increasing incidence of breast cancer, the rising number of breast cancer surgeries, and growing awareness on the early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period.
Some of the key players in the breast lesion localization methods market are C.R. Bard (US), Ranfac Corporation (US), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (US), SurgicEye GmbH (Germany), Intra-Medical Imaging LLC (US), IsoAid, LLC (US), Cianna Medical (US), Endomagnetics Ltd. (UK), and Cook Medical (US). The study includes an in-depth competitive analysis of these key players in the breast lesion localization methods market, along with their company profiles, recent developments, and key market strategies.
The wire localization segment held the largest share of the breast lesion localization methods market in 2018
Based on type, the breast lesion localization methods market is divided into five major segments: wire localization, isotope localization, magnetic localization, electromagnetic localization, and others. The wire localization segment accounted for the largest share of the breast lesion localization methods market in 2018. The large share of this segment is attributed to its accuracy in abnormal tissue localization, minimum removal of normal tissues, minimal scarring, and the availability of reimbursement for breast lesion localization devices.
Asia Pacific projected to grow at the highest CAGR during the forecast period
The Asia Pacific is projected to record the highest growth in the breast lesion localization methods market during the forecast period. The rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness is the major factors supporting the growth of the Asia Pacific breast lesion localization methods market.
Key Topics Covered
1 Introduction
2 Research Methodology
2.1 Research Design
2.2 Market Breakdown and Data Triangulation
2.3 Market Size Estimation
2.4 Primary Research (Interviews) - Sampling Frame
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rising Incidence of Breast Cancer
4.2.1.2 Increasing Number of Breast Cancer Surgeries
4.2.1.3 Increasing Awareness on the Early Detection of Breast Cancer
4.2.2 Restraints
4.2.2.1 Uncertainty in Regulatory Approval Procedures
4.2.2.2 Visionary Leaders
4.2.3 Opportunities
4.2.3.1 Increasing Adoption of Technologically Advanced Electromagnetic Reflectors
4.2.3.1 Dearth of Oncologists
4.2.4 Challenges
4.2.4.1 Dearth of Oncologists
5 Breast Lesion Localization Methods Market, By Type, Million Procedures/USD Million (2016-2024)
5.1 Introduction
5.2 Wire Localization
5.3 Radioisotope Localization
5.3.1 Radioguided Occult Lesion Localization
5.3.2 Radioactive Seed Localization
5.4 Electromagnetic Localization
5.5 Magnetic Localization
5.6 Other Localization Methods
6 Breast Lesion Localization Methods Market, By Usage, Million Procedures (2016-2024)
6.1 Introduction
6.2 Tumor Identification
6.3 Sentinel Lymph Node Identification
6.3.1 Lumpectomy
6.3.2 Mastectomy
7 Breast Lesion Localization Methods Market, By Region, Million Procedures (2016-2024)
7.1 Introduction
7.2 Asia Pacific
7.3 Europe
7.4 North America
7.4.1 US
7.4.2 Canada
7.5 Rest of the World
8 Competitive Landscape
8.1 Overview
8.2 Competitive Leadership Mapping
8.2.1 Strength of Product Portfolio
8.2.2 Business Strategy Excellence
8.3 Competitive Scenario
8.4 End User Preference Study
8.4.1 Breast Lesion Localization Methods: Comparative Analysis
8.4.2 Breast Lesion Localization Methods: Selection Criteria Evaluation
8.4.3 Qualitative Assessment of Replacement Trend
9 Company Profile
9.1 Overview Argon Medical Devices
9.1.1 Business Overview
9.1.2 Product Offered
9.2 B.D. Company
9.3 Cianna Medical
9.4 Cook Medical
9.5 Endomagnetics Ltd.
9.6 Health Beacon
9.7 Intra-Medical Imaging LLC
9.8 Isoaid LLC
9.9 Leica Biosystems
9.10 SOMATEX Medical Technologies GmbH
9.11 Surgiceye GmbH
9.12 Ranfac Corporation
For more information about this report visit https://www.researchandmarkets.com/r/91f4x5
